FDA Inspection
PPD Development, L.P.PPD Development, L.P. – FDA Inspection, Mar 3, 2017
Record Details
This FDA Inspection record concerns PPD Development, L.P., with an inspection on March 3, 2017, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · 8560cfe7-e49a-4392-bc16-13cce3e5d79a
Inspection Facts
- Inspection number
- 1006643
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of PPD Development, L.P.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 1, 2026 | Not classified | Minneapolis District Office | |
| September 25, 2025 | VAI | Minneapolis District Office | Drug Quality Assurance |
| April 5, 2023 | NAI | Minneapolis District Office | |
| July 16, 2021 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 19, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for PPD Development, L.P.
- FDA Inspection 1320960 - 2026-05-01
- FDA Inspection 1284012 - 2025-09-25
- FDA Inspection 1202015 - 2023-04-05
- FDA Inspection 1146503 - 2021-07-16
- FDA Inspection 1105196 - 2019-09-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.